Samsung Bioepis Receives EC’s Marketing Authorization for Epysqli (biosimilar, eculizumab) to Treat Paroxysmal Nocturnal Hemoglobi...
Shots: The EC has granted marketing authorization for Epysqli, a biosimilar refere...
Sandoz Reports the EMA Acceptance of MAA for Proposed Biosimilar Denosumab
Shots: The EMA has accepted the MAA for the proposed biosimilar denosumab (Prolia...
Celltrion’s Yuflyma (biosimilar, adalimumab) Receives the US FDA’s Approval for Multiple Indications
Shots: The US FDA has approved Yuflyma (adalimumab-aaty) as the ninth biosimilar r...
Amneal Reports the Commercial Availability of Fylnetra (biosimilar, pegfilgrastim) in the US
Shots: The company launch Fylnetra, a biosimilar referencing Neulasta in the US ma...
Sandoz Entered into an Agreement with Just - Evotec Biologics to Develop and Manufacture Multiple Biosimilar
Shots: The companies collaborated to develop and manufacture multiple biosimilar p...
Alvotech Reports an Initiation of AVT05, a Proposed Biosimilar for Simponi and Simponi Aria to Treat Moderate to Severe Rheumatoid...
Shots: The company initiates the P-II confirmatory patient study of AVT05, a biosi...
